About Nanopath
Nanopath is a company based in Cambridge (United States) founded in 2019 by Alison Burklund and Amogha Tadimety.. Nanopath has raised $10 million across 5 funding rounds from investors including NIH, Norwest Venture Partners and National Science Foundation. Nanopath offers products and services including Molecular Diagnostic Platform. Nanopath operates in a competitive market with competitors including N-of-One, OrigiMed, Range Bio, Coral Genomics and VSense, among others.
- Headquarter Cambridge, United States
- Founders Alison Burklund, Amogha Tadimety
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanopath Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 5 rounds
-
Latest Funding Round
$5.34 M (USD), Debt – Conventional
Jan 24, 2025
-
Investors
NIH
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanopath
Nanopath offers a comprehensive portfolio of products and services, including Molecular Diagnostic Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables scalable point-of-care testing for disease diagnosis.
Funding Insights of Nanopath
Nanopath has successfully raised a total of $10M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $5.34 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Conventional — $5.3M
-
First Round
First Round
(01 Jan 2022)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Debt – Conventional - Nanopath | Valuation |
investors |
|
| May, 2024 | Amount | Grant - Nanopath | Valuation |
investors |
|
| Mar, 2024 | Amount | Grant - Nanopath | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanopath
Nanopath has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Norwest Venture Partners and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location | |
|
Capital is provided to women-led ventures in early stages.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanopath
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanopath
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanopath Comparisons
Competitors of Nanopath
Nanopath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as N-of-One, OrigiMed, Range Bio, Coral Genomics and VSense, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular profiles are analyzed for clinical decision support in oncology.
|
|
| domain | founded_year | HQ Location |
Genetic sequencing is utilized for personalized cancer diagnostics and counseling.
|
|
| domain | founded_year | HQ Location |
Provider of solutions for health monitoring based on translational proteomics
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed for personalized drug development optimization.
|
|
| domain | founded_year | HQ Location |
Developer of semiconductor biosensor technology
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nanopath
When was Nanopath founded?
Nanopath was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Nanopath located?
Nanopath is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Nanopath?
Alison Burklund is the current CEO of Nanopath. They have also founded this company.
Is Nanopath a funded company?
Nanopath is a funded company, having raised a total of $10M across 5 funding rounds to date. The company's 1st funding round was a Grant of $996.73K, raised on Jan 01, 2022.
What does Nanopath do?
Nanopath was founded in 2019 and is based in Cambridge, United States. A nanotechnology-based platform for point-of-care molecular diagnostics in womens health is developed and offered. Assay development is focused on pelvic and gynecologic infections to enhance patient outcomes through improved diagnostic processes. Operations center on advancing the sectors diagnostic capabilities in a clinical setting.
Who are the top competitors of Nanopath?
What products or services does Nanopath offer?
Nanopath offers Molecular Diagnostic Platform.
Who are Nanopath's investors?
Nanopath has 8 investors. Key investors include NIH, Norwest Venture Partners, National Science Foundation, SV Health Investors, and GingerBread Capital.